GWS
SPPI

Glassman Wealth Services’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Glassman Wealth Services’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3
Closed – – 1674
2019
Q4 		$0 Buy
+3
New +$24 ﹤0.01% 1567

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Glassman Wealth Services's SPPI Position: Q1 2020 in Review

Glassman Wealth Services sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2020, closing a stake of 3 shares.

Glassman Wealth Services first reported a position in SPPI in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 156 funds tracked by Wall St. Rank hold SPPI as of Q1 2020.

  • Glassman Wealth Services reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
  • Glassman Wealth Services sold 3 Spectrum Pharmaceuticals Inc shares in Q1 2020.
  • Glassman Wealth Services first reported a position in Spectrum Pharmaceuticals Inc in Q4 2019 and held it in 1 quarter.
  • Glassman Wealth Services's Spectrum Pharmaceuticals Inc position peaked at $0 in Q4 2019.
  • 156 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2020.

Based on Glassman Wealth Services's 13F filing for Q1 2020, filed 12 May 2020.